Article Figures & Tables
Figures
- Figure 1:
Predicted probabilities of cost-related nonadherence among Canadians by income level. Error bars indicate 95% confidence intervals. Income levels are based on annual household incomess: low = less than $20 000, low/medium = $20 000–$39 999, medium = $40 000–$59 999, medium/high = $60 000–$79 999, high = $ 80 000 or more.
Tables
- Table 1:
Characteristics and prevalence of cost-related nonadherence among respondents to the Canadian Community Health Survey in 2007
- Table 2:
Factors associated with cost-related nonadherence among respondents to the Canadian Community Health Survey 2007 who reported having received one or more prescriptions for medication
In this issue
Article tools
Respond to this article
The effect of cost on adherence to prescription medications in Canada
Jump to section
Related Articles
Cited By...
- The mirage of universality: Canadas failure to act on social policy and health care
- Exploring the experiences of people in Ontario, Canada who have trouble affording medicines: a qualitative concept mapping study
- Compliance packaging: Be aware of the hidden cost
- Acceptability and feasibility of a national essential medicines list in Canada: a qualitative study of perceptions of decision-makers and policy stakeholders
- Prescription medication nonadherence associated with food insecurity: a population-based cross-sectional study
- Demographic characteristics and cost of treatment among oncology patients in a publicly funded system, the Ontario Trillium Drug Program: a retrospective cohort study
- Should national pharmacare apply a value-based insurance design?
- Impact of a household-level deductible on prescription drug use among lower-income adults: a quasi-experimental study
- Public prescription drug plan coverage for antiretrovirals and the potential cost to people living with HIV in Canada: a descriptive study
- Patterns of borrowing to finance out-of-pocket prescription drug costs in Canada: a descriptive analysis
- Improving the quality of health care in Canada
- The consequences of patient charges for prescription drugs in Canada: a cross-sectional survey
- Testing and treatment for obstructive sleep apnea in Canada: funding models must change
- Social considerations of inflammatory bowel disease in Southern Israel
- Protocol for a randomised controlled trial evaluating the effects of providing essential medicines at no charge: the Carefully seLected and Easily Accessible at No Charge Medicines (CLEAN Meds) trial
- Impact of income-based deductibles on drug use and health care utilization among older adults
- Lacces aux medicaments par lhospitalisation
- Medication access via hospital admission
- Liste canadienne des medicaments essentiels: Potentiel et incertitudes
- Canadian list of essential medications: Potential and uncertainties
- Potential contribution of lifestyle and socioeconomic factors to healthy user bias in antihypertensives and lipid-lowering drugs
- The effects of catastrophic drug plan deductibles on older women's use of cardiovascular medicines: a retrospective cohort study
- Estimated effects of adding universal public coverage of an essential medicines list to existing public drug plans in Canada
- Development of a preliminary essential medicines list for Canada
- Cost-related non-adherence to prescribed medicines among older adults: a cross-sectional analysis of a survey in 11 developed countries
- Cost-related nonadherence to prescribed medicines among older Canadians in 2014: a cross-sectional analysis of a telephone survey
- Estimated cost of universal public coverage of prescription drugs in Canada
- Concretiser les promesses du regime d'assurance-maladie
- Delivering on the promise of Medicare
- Addressing cost-related barriers to prescription drug use in Canada
- Chronic Physical and Mental Health Conditions among Adults May Increase Vulnerability to Household Food Insecurity
- The road to competitive generic drug prices in Canada
- Universal Drug Coverage and Socioeconomic Disparities in Major Diabetes Outcomes
- Leadership on prescription drugs needed